Ras Blockade | List of Frontiers open access articles

Original Research

Published on 09 Jun 2021

Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats

in Renal Physiology and Pathophysiology

José Wilson N. Corrêa
Karoline R. Boaro
Letícia B. Sene
Juliano Z. Polidoro
Thiago A. Salles
Flavia L. Martins
Lusiane M. Bendhack
Adriana C. C. Girardi

Frontiers in Physiology

doi 10.3389/fphys.2021.656460

4,081 views
3 citations

Original Research

Published on 18 Sep 2019

Renoprotection Provided by Additional Diuretic Treatment in Partially Nephrectomized Ren-2 Transgenic Rats Subjected to the Combined RAS and ETA Blockade

in Renal Physiology and Pathophysiology

Ivana Vaněčková
Silvie Hojná
Zdenka Vernerová
Michaela Kadlecová
Hana Rauchová
Elzbieta Kompanowska-Jezierska
Zdeňka Vaňourková
Luděk Červenka
Josef Zicha

Frontiers in Physiology

doi 10.3389/fphys.2019.01145

3,781 views
2 citations

Original Research

Published on 07 Oct 2024

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice

in Renal Pharmacology

Nerea Martos-Guillami
Ander Vergara
Carmen Llorens-Cebrià
Aku Enam Motto
Irene Martínez-Díaz
Francisco Gonçalves
Maria Magdalena Garcias-Ramis
Estibaliz Allo-Urzainqui
Alonso Narváez
Sheila Bermejo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415879

5,932 views
8 citations

Mini Review

Published on 11 Aug 2020

Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders

in Geriatric Medicine

Aline Silva de Miranda
Antonio Lucio Teixeira

Frontiers in Medicine

doi 10.3389/fmed.2020.00515

5,160 views
10 citations

Original Research

Published on 02 Jun 2021

Inhibition of the Renin-Angiotensin System Reduces Gene Expression of Inflammatory Mediators in Adipose Tissue Independent of Energy Balance

in Obesity

Caitlin S. Mitchell
Shirmila D. Premaratna
Garth Bennett
Maria Lambrou
Lauren A. Stahl
Markandeya Jois
Elizabeth Barber
Christopher P. Antoniadis
Stephen C. Woods
David Cameron-Smith

Frontiers in Endocrinology

doi 10.3389/fendo.2021.682726

7,194 views
17 citations

Original Research

Published on 17 Aug 2022

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway

in Renal Pharmacology

Yan-Ni Wang
Hong-Jiao Liu
Li-Li Ren
Ping Suo
Liang Zou
Ya-Mei Zhang
Xiao-Yong Yu
Ying-Yong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.964370

5,986 views
29 citations

Articles

Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats

Renoprotection Provided by Additional Diuretic Treatment in Partially Nephrectomized Ren-2 Transgenic Rats Subjected to the Combined RAS and ETA Blockade

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice

Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders

Inhibition of the Renin-Angiotensin System Reduces Gene Expression of Inflammatory Mediators in Adipose Tissue Independent of Energy Balance

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway